Dissemin is shutting down on January 1st, 2025

Published in

Wiley, British Journal of Haematology, 5(180), p. 757-760, 2016

DOI: 10.1111/bjh.14449

Links

Tools

Export citation

Search in Google Scholar

Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO